BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 6, 2008
View Archived Issues
Recombinant BDNF fusion protein protects against Abeta-induced learning deficits
Read More
Positive preclinical results of new dengue virus vaccine candidates
Read More
Positive immunological data reported for ATX-MS-1467 in multiple sclerosis
Read More
PHOENIX 1 results show long-term efficacy of ustekinumab in psoriasis
Read More
Novel panErbB kinase inhibitor with potential against intracranial tumors profiled
Read More
Beta-blocker nadolol well tolerated and beneficial in asthma patients
Read More
Amgen and Takeda enter collaboration in Japan on up to 13 Amgen candidates
Read More
New treatments for arthritis and other inflammatory disorders disclosed in recent patent literature
Read More
Novel analgesic agents imparted in recent patents
Read More
New therapeutic agents for diabetes described in recent patents
Read More
Novel atypical antipsychotic drug profiled at Neurosearch
Read More
Biovitrum initiates process to move focus to specialist care diseases
Read More
SciClone initiates phase II trial of RP-101 in late-stage pancreatic cancer
Read More
Ziopharm initiates dosing in phase I/II studies of indibulin and palifosfamide
Read More
Solbec's Coramsine treatment discontinued in renal cell carcinoma patient
Read More
Biogen Idec submits IND application for BIIB-015
Read More
Advanced Cell Technology completes pre-IND meeting with FDA for RPE cell therapy
Read More
Alchemia reaches agreement with FDA to initiate clinical trial of HyCAMP
Read More
Progen executes definitive agreement to acquire CellGate
Read More
The FDA has accepted for review Centocor's BLA for ustekinumab for plaque psoriasis
Read More
Seaside awards USD 4.5 million collaborative research contract to Vanderbilt University
Read More
Zydus Cadila enters into collaborations with Prolong and Karo Bio
Read More
ActivBiotics receives orphan drug designation from the EMEA for M-40403
Read More
Alexza initiates AZ-007 phase I clinical trial
Read More
Dosing completed in first cohort in formal pharmacokinetic study for Zenvia
Read More